Of note, the iMODERN trial had also excluded people with a history of prior STEMI, chronic total occlusion, complex ...

HF outcomes at 3 years were improved, but where stem cells fit in future research is the big unknown, says Jay Traverse.

Physicians will remain in the loop, but AI can “turbocharge and augment our abilities,” an emergency medicine physician says.

Compared with the standard of care, an AI-based ECG model greatly reduced false positives for ST-elevation myocardial ...

Philips (NYSE: PHG) today announced results from the iMODERN trial evaluating immediate versus delayed treatment of narrowed ...

Durham, NC - An initial dose of 162-mg aspirin may be as effective as and perhaps safer than 325 mg for the acute treatment of ST-elevation MI (STEMI), a new study suggests [1]. The study, published ...

Hamilton, ON - Further analysis of the RIVAL trial has confirmed that the radial approach to PCI when performed by experienced operators shows major benefits over femoral for STEMI patients [1].

A new study finds that patients who suffer a STEMI heart attack while hospitalized are 10 times more likely to die than patients who suffer a STEMI outside the hospital. If you suffer a heart attack ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Age-related vulnerable characteristics of pancoronary plaques in patients with ST-segment elevation ...